Cancer Incidence after Initiation of Antimuscarinic Medications for Overactive Bladder in the United Kingdom: Evidence for Protopathic Bias.
Saved in:
| Title: | Cancer Incidence after Initiation of Antimuscarinic Medications for Overactive Bladder in the United Kingdom: Evidence for Protopathic Bias. |
|---|---|
| Authors: | Kaye JA; Epidemiology, RTI Health Solutions, Waltham, Massachusetts., Margulis AV; Epidemiology, RTI Health Solutions, Barcelona, Spain., Fortuny J; Epidemiology, RTI Health Solutions, Barcelona, Spain., McQuay LJ; Epidemiology, Data Analysis, RTI Health Solutions, Durham, North Carolina., Plana E; Biostatistics, RTI Health Solutions, Barcelona, Spain., Bartsch JL; Biostatistics, RTI Health Solutions, Durham, North Carolina., Bui CL; Epidemiology, RTI Health Solutions, Durham, North Carolina., Perez-Gutthann S; Epidemiology, RTI Health Solutions, Barcelona, Spain., Arana A; Epidemiology, RTI Health Solutions, Barcelona, Spain. |
| Source: | Pharmacotherapy [Pharmacotherapy] 2017 Jun; Vol. 37 (6), pp. 673-683. Date of Electronic Publication: 2017 May 29. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 8111305 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1875-9114 (Electronic) Linking ISSN: 02770008 NLM ISO Abbreviation: Pharmacotherapy Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1875-9114 |
|---|---|
| DOI: | 10.1002/phar.1932 |
